bioRxiv Science⌕ Search

Biology subjects

Kulygina, J.

Publications and source records attributed to Kulygina, J..

2 recordsLinked to original sources

Bayesian Network Analysis Identifies PREX1 as a Master Regulator of Cytoskeletal Disruption in Inflammatory Bowel Disease

BackgroundInflammatory bowel diseases are complex multifactorial and polygenic conditions with incompletely understood etiology. Transcriptomic and metabolomic studies reveal hundreds of genes and metabolites associated with the inflammatory dowel diseases (IBD), while about 240 genetic loci are associated with these diseases. IBD are accompanied by numerous epithelial lesions including epithelial cells damage and barrier dysfunction. Recent studies suggest that cytoskeleton dysregulation underlies these aspects of IBD. We have previously shown that the disruption of cortical actin filaments and microvilli degeneration are characteristic of Muc2 mouse IBD model. MethodsWe used transmission electron microscopy to evaluate ultrastructural defects in the intestinal epithelium of IBD patients. A probabilistic graphical model (Bayesian network) was employed in order to identify the key gene network hierarchy that might define cytoskeletal architecture among other regulatory events in IBD. The Bayesian network was based on preselected key node genes from open access transcriptomic data obtained in patients with Crohns disease. ResultsElectron microscopy of IBD patients demonstrated disruption of the brush border ultrastructure, similar to the microvillar defects previously described in Muc2 colitis model mice. We highlighted a list of genes contributing to actin polymerization and bundling, of which PREX1 were further confirmed using the transcriptome data obtained from Muc2 mice. ConclusionOur study underscores the utility of Bayesian network analysis in complex cellular phenotypes that helped to identify potential target genes responsible for cortical cytoskeleton and microvilli disruption upon chronic intestinal inflammation.

bioinformatics↗

F-actin dynamics couples sphingolipid metabolism to epithelial barrier integrity in chronic colitis

BackgroundIntestinal barrier dysfunction is a hallmark of inflammatory bowel diseases (IBD). This condition causes intoxication and immune hyperactivation. Understanding the events underlying epithelial barrier disruption during chronic inflammation is key to developing barrier-restoring therapies. Filamentous actin (F-actin) is essential for maintaining polarity and junctional integrity. However, the contribution of F-actin dynamics to IBD-associated barrier dysfunction remains unclear. ObjectiveWe aimed to examine actin cytoskeleton integrity during chronic colitis across mouse models and human patients and identify potential regulators of cytoskeleton dynamics. DesignF-actin and junctional proteins were analyzed in three models of chronic colitis (Muc2 KO, DSS-induced colitis, adoptive transfer colitis) using confocal microscopy. Claudin-3 interactors were identified by immunoprecipitation and proteomics. Intestinal organoids were used to assess the effect of F-actin disruption on barrier integrity. Metabolomic and gene expression analyses identified candidate pathways, further validated by chemical inhibition. Biopsies from patients with ulcerative colitis (UC) were examined using transmission electron microscopy and confocal microscopy. ResultsDisrupted actin dynamics emerged as a critical driver of epithelial barrier dysfunction in chronic colitis. An imbalance between polymeric and monomeric actin impaired barrier integrity in vivo and in 3D organoids. Immunoprecipitation identified actin and associated factors as the primary interactors of claudin-3 with reduced interaction during inflammation. Ceramide metabolism was revealed as a potential regulator of F-actin and intestinal barrier. In UC patients, we confirmed concurrent disruption of junctions and F-actin. ConclusionsF-actin dysregulation contributes to barrier dysfunction in IBD and targeting its modulators, including ceramide biosynthesis, represents a novel therapeutic strategy. WHAT IS ALREADY KNOWN ON THIS TOPICO_LIEpithelial damage and increased paracellular permeability are key characteristics of inflammatory bowel diseases. C_LIO_LIParacellular permeability is partially attributed to the downregulation of junction proteins but this mechanism does not explain all clinical observations. C_LIO_LIIn the Muc2 KO mouse model of chronic colitis, F-actin organization and membrane localization of tight junction protein claudin-3 are disrupted, although protein expression levels remain unchanged. C_LI WHAT THIS STUDY ADDSO_LIF-actin dynamics is impaired in the intestinal epithelium across three different mouse models of chronic colitis and IBD patients. C_LIO_LIDisruption of F-actin dynamics leads to impaired membrane localization of tight and adherens junction proteins and increased intestinal epithelial permeability in vivo and in colonic organoids. C_LIO_LIInhibition of ceramide biosynthesis rescues F-actin polymerization and intestinal barrier integrity in mouse chronic colitis models. C_LI HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICYO_LITargeting F-actin dynamics is a promising approach to improve gut epithelial integrity. C_LIO_LI"Ceramide-F-actin-junction" axis is proposed as one of the mechanisms behind epithelial barrier disruption in colitis. Therapeutic targeting of this axis represents a promising path for restoring gut integrity. C_LI

cell biology↗